Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost modeling for alternate routes of administration of opioids for cancer pain.

S J Hassenbusch1

  • 1Department of Neurosurgery, M. D. Anderson Cancer Center, Houston, Texas, USA.

Oncology (Williston Park, N.Y.)
|June 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of clonidine hydrochloride injections for epidural intrathecal administration.

International journal of pharmaceutical compounding·2013
Same author

Cost effectiveness of intrathecal therapy for pain.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Alternative intrathecal agents for the treatment of pain.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Future trends in the development of local drug delivery systems: intraspinal, intracerebral, and intraparenchymal therapies.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

Preclinical toxicity study of intrathecal administration of the pain relievers dextrorphan, dextromethorphan, and memantine in the sheep model.

Neuromodulation : journal of the International Neuromodulation Society·2011
Same author

A method for training physicians to implant intrathecal catheters.

Neuromodulation : journal of the International Neuromodulation Society·2011

Intrathecal pain management with implanted pumps becomes cost-effective within 3-6 months compared to external pumps. Spinal delivery is more economical than systemic treatments within 1.5-2.5 years.

Area of Science:

  • Health Economics
  • Pain Management
  • Medical Technology

Background:

  • Neuraxial infusion offers various pain management strategies.
  • Economic evaluations are crucial for healthcare decisions.

Purpose of the Study:

  • To analyze the economic viability of different pain management delivery systems.
  • To determine cost-effectiveness breakeven points for neuraxial infusion methods.

Main Methods:

  • Development of a theoretical predictive economic model using a computer spreadsheet.
  • Analysis based on four levels of supportive data.
  • Comparison of intrathecal/implanted pumps versus epidural/external pumps and systemic treatments.

Main Results:

Related Experiment Videos

  • The breakeven point for intrathecal/implanted pumps versus epidural/external pumps is 3-6 months.
  • The breakeven point for spinal delivery (implanted system) versus systemic treatment is 1.5-2.5 years.

    • Conclusions:

    • Implanted intrathecal pumps present a cost-effective alternative to external pumps for long-term pain management.
    • Spinal delivery systems demonstrate economic advantages over systemic treatments over extended periods.